In an exclusive interview with CNBC-TV18, Rakesh Parikh CFO of Unichem Laboratories says the company’s Q4 outlook is on the lines of the Q3 growth and the investments made are likely to reap benefits soon. “The India formulation business is continuing in the same as in Q3. We will wrap up the year with double digit growth.”
first published: Mar 31, 2011 01:45 pm
A collection of the most-viewed Moneycontrol videos.
Nifty recovers from day’s low to edge back above 26,000 | Closing Bell Live
Tax Saving Tips: How sections 54 & 54F can reduce tax to zero
Can Nifty Extend Its Upmove After Back-To Back Gains? Insurance Stocks In Focus| Opening Bell Live
From Mini-Mumbai to the Real Mumbai: What Brought This Tenant to Andheri | The Tenant
